Medical/Pharmaceuticals
Marketing Authorization Application for Luye Pharma's Rivastigmine Multi-Day Transdermal Patch Product Rivalif® under Review at EU Competent Authorities
MISBACH, Germany, May 20, 2020 /PRNewswire/ -- Luye Pharma Group announced today that the Marketing Authorization Application (MAA) within the European territory for its Rivastigmine Multi-Day Transdermal Patch (Brand Name: Rivalif® , Product Code: LY30410), an innovative drug delivery system, is ...
2020-05-20 19:34
3483
Retailers Rely on DERMALOG's Fever Screening
The Corona pandemic poses significant challenges for retail stores and shopping centers. Businesses must implement numerous health protection measures without compromising customer experience too much. This is why German Scandinavian Park mall has opted for DERMALOG's non-contact fever detection....
2020-05-20 19:27
2391
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
- Publication in Nature Communications demonstrates generation of robust neutralizing antibodies and T cell responses against SARS-CoV-2 - Preliminary safety and immune responses data from Phase 1 clinical trial expected in June - Multiple animal challenge study data expected in coming weeks ...
2020-05-20 19:00
3058
COUCH Health Demands the Clinical Research Industry Improves Participant Diversity
As advocates of diverse and inclusive clinical trials, patient engagement agency COUCH Health is calling on the industry take action to make clinical research more inclusive and representative of all populations. Demand Diversity has launched with the aim to raise awareness of the lack of diversi...
2020-05-20 16:00
1313
It's time to talk: Relationships Australia NSW launches free telephone hotline
SYDNEY, May 20, 2020 /PRNewswire/ -- Relationships Australia NSW has launched
Time 2 Talk, a brand-new telephone hotline that provides support and advice to
help Australians navigate the complexities of day-to-day living amid COVID-19.
2020-05-20 14:28
2975
DKSH partners with International SOS to safeguard staff and supply chain operations during COVID-19
BANGKOK, May 20, 2020 /PRNewswire/ -- DKSH, Asia's leading Market Expansion
Services provider for companies seeking to grow their business inAsia and
beyond, has entered into a partnership with International SOS, to run DKSH's
Total Quarantine Solution in several markets acrossAsia.
2020-05-20 12:00
2752
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen
* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy...
2020-05-20 10:40
7474
Glemser Technologies and Arria NLG announce strategic partnership
Together they will accelerate pharma clients' ability to bring life-saving drugs to market through automation of medical and regulatory report writing NEW YORK, May 20, 2020 /PRNewswire/ -- Arria NLG, a leading provider of Natural Language Generation (NLG) technology, today announced a collaborat...
2020-05-20 01:45
3471
Covis Pharma B.V. Initiates Phase 3 Clinical Trial of Alvesco (Ciclesonide) Inhaler for the Treatment of COVID-19
U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) filing to study the use of Alvesco in COVID-19 Study will evaluate the Safety and Efficacy of Alvesco in the Treatment of Non-hospitalized COVID-19 Patients Aged 12 and Above LUXEMBOURG and ZUG, Swi...
2020-05-19 20:00
1683
TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
Minimum dose of hydromethylthionine could slow clinical decline and brain atrophy in behavioural variant Fronto-Temporal Dementia as well as Alzheimer's Disease ABERDEEN, Scotland and SINGAPORE, May 19, 2020 /PRNewswire/ -- In a paper published online in theJournal of Alzheimer's Disease ( https...
2020-05-19 19:00
2337
QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development
NEWARK, Delaware, May 19, 2020 /PRNewswire/ -- QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics. QPS announces an expanded and up...
2020-05-19 18:55
3124
Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States
SAN DIEGO, May 19, 2020 /PRNewswire/ -- Invivoscribe to offer the LeukoStrat® CDxFLT3 Mutation Assay as an FDA approved kit with analysis software. In 2017, Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay became the first FDA approvedFLT3 test and launched as a testing service at LabPMM, Invi...
2020-05-19 18:00
2993
Half-year Figures: ZEISS Looks Back on Good First Six Months Overall
Half-year revenue reaches 3.2 billion euros (+6% compared to prior year) – EBIT at455 million euros (+12 million euros compared to prior year) - The Semiconductor Manufacturing Technology and Medical Technology segments contributed in particular to growth in the first six months - Initial impact...
2020-05-19 17:00
2150
Mentice Launches Seventh Generation Platform Aimed to Transform Endovascular Therapy
VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications GOTHENBURG, Sweden, May 19, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), today announced the global introduction of its seventh-generation simulation platform - VIST®...
2020-05-19 16:20
2087
Chinese company Daddybaby applies for international PPE certification
FUZHOU, China, May 19, 2020 /PRNewswire/ -- Daddybaby Co. Ltd. has retooled its production lines and joined the fight to deliver more personal protective equipment (PPE) to the populations in many countries. As the daily number of COVID-19 infections inChina has significantly dropped and the situ...
2020-05-19 14:55
1583
Excelra to Provide Lawrence Livermore National Laboratory With Small Molecule Medicinal Chemistry Intelligence Data to Help Develop Drug Design Platform
HYDERABAD, India, May 19, 2020 /PRNewswire/ -- Under a three-year agreement,
Excelra
2020-05-19 10:00
3000
Aetna International announces partnership with leading mental well-being app Wysa, as part of enhanced mental well-being support for members during COVID-19 pandemic
SINGAPORE, May 19, 2020 /PRNewswire/ -- Aetna International has today announced that it is partnering with Wysa, a confidential and anonymous mental well-being app and service, as part of the company's ongoing efforts to address the 'second curve' of the COVID-19 pandemic, the less visible but in...
2020-05-19 10:00
3586
Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections
SHANGHAI and SAN FRANCISCO, May 19, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced dosing of the first Chinese patient in the global ATTACK (Acinetobacter Treatment Trial Against Colistin) Phase 3 registrational trial...
2020-05-19 09:45
3207
Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic
* Exyte offers the new ExyCell® modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP). * Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreac...
2020-05-19 08:15
4751
WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States
SHANGHAI and WORCESTER, Mass., May 19, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced today the successful signing of a land deal for WuXi Bio...
2020-05-19 08:00
2921
Week's Top Stories
Most Reposted
ASTON MARTIN ARAMCO FORMULA ONE® TEAM ANNOUNCE PEPPERSTONE AS OFFICAL TRADING PARTNER
[Picked up by 308 media titles]
2025-01-07 09:00
RuggON Unveils VORTEX Vehicle Mount Computer with AI-Enhanced, SATCOM-Ready
[Picked up by 306 media titles]
2025-01-06 21:00
Brewing Connections and Spotlighting Café Culture: MIFB 2025 Hosts MNCC in Collaboration with MSCA
[Picked up by 305 media titles]
2025-01-06 14:00
iWOW Unveils Age-Tech Innovations at CES 2025, Expanding Portfolio of IoT Solutions for Ageing-In-Place
[Picked up by 294 media titles]
2025-01-07 21:18CELEBRATE THE LUNAR NEW YEAR 2025 AT HOIANA RESORT & GOLF, WORLD'S LEADING FULLY INTEGRATED RESORT
[Picked up by 290 media titles]
2025-01-06 19:25
Most Read
Interest-Driven Consumption Sparks ¥ 500B ACG Goods Market, MINISO Rides the Wave
2025-01-03 19:33
10980
